Trifecta Capital Advisors’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $20.3K | Hold |
245
| – | – | ﹤0.01% | 216 |
|
|
2025
Q1 | $19.9K | Hold |
245
| – | – | ﹤0.01% | 186 |
|
|
2024
Q4 | $22.1K | Hold |
245
| – | – | ﹤0.01% | 185 |
|
|
2024
Q3 | $24.2K | Hold |
245
| – | – | 0.01% | 178 |
|
|
2024
Q2 | $22.7K | Hold |
245
| – | – | 0.01% | 181 |
|
|
2024
Q1 | $23.2K | Hold |
245
| – | – | 0.01% | 170 |
|
|
2023
Q4 | $21.9K | Hold |
245
| – | – | 0.01% | 170 |
|
|
2023
Q3 | $17.9K | Hold |
245
| – | – | 0.01% | 183 |
|
|
2023
Q2 | $20.4K | Hold |
245
| – | – | 0.01% | 181 |
|
|
2023
Q1 | $18.7K | Hold |
245
| – | – | 0.01% | 188 |
|
|
2022
Q4 | $20.3K | Buy |
+245
| New | +$20.3K | 0.01% | 172 |
|